Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Northwestern University
This study seeks to evaluate the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs. absence of treatment for actinic keratoses
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age greater than or equal to 18 years
Have a t least 4 nonhypertrophic AK lesions on the body
The subjects are in good health
The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate to the investigator
You may not be if
Subjects who are pregnant or lactating
Subjects with a history of cutaneous photosensitivity or porphyria, hypersensitivity to porphyrins, or photodermatosis
Subjects with use of photosensitizing drugs within 1 week of study start
Subjects with use of topical medications such as corticosteroids, alpha-hydroxyacids or retinoids 2 weeks before study entry
Subjects with systemic steroid therapy within 4 weeks before study entry
Subjects who received previous treatment of target AKs
Subjects with systemic treatment with chemotherapeutic agents, masoprocol (Actinex), immunotherapy, or retinoids within 2 months of study entry
Subjects with prior history of hypersensitivity reactions to lidocaine
Subjects who are unable to understand the protocol or to give informed consent
Clareo Health | A Photodynamic Therapy for Treatment of Actinic Keratoses
